All In MedTech

FDA Clearance Tracker · P130008-S056

Inspire Programmer System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 12, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P130008-S056
Device name
Inspire Programmer System
Applicant location
Maple Grove, MN
Received
Jul 31, 2020
Decided
Feb 12, 2021
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P130008

Device type

Device class
Class III

Every decision under product code MNQ

FDA's approval statement

As written in FDA's record.

Approval for:1) Updated version of the Model 2740 Inspire Programmer System;2) Minor software changes to the Application Module (AM)/Tablet;3) Manufacturing process changes to reduce scrap for the new programmer cable;4) Changes to improve aesthetics of the programmer cable; and5) Minor software updates regarding non-English languages for the European market and minor bug fixes.

Source documents

Other decisions for Inspire Medical Systems

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.